Dermira Inc.

Dermira Inc.
Stock Exchange NASDAQ Stock Market
EPS
$5.34
Market Cap
$483.55 M
Shares Outstanding
53.67 M
Public Float
31.97 M

Profile

Address
275 Middlefield Road
Menlo Park California 94025
United States
Employees -
Website http://www.dermira.com
Updated 07/08/2019
Dermira, Inc. is a biopharmaceutical company, which engages in the provision of biotech ingenuity to medical dermatology. It focuses on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis, psoriasis, and acne. The company was founded by Thomas G.

Financials

View All
Created with Highcharts 5.0.14Dermira Inc.Net Income. Fiscal year is January-December. All values USD Thousands.22 35022 35031 87531 87578 39978 39989 08489 084303 261303 261221 540221 5402013201420152016201720180100k200k300k400k
Created with Highcharts 5.0.14Dermira Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.007 3007 3007 3007 30022 58522 5854 5414 54142 33942 339201320142015201620172018010k20k30k40k50k

Thomas G. Wiggans
Chairman & Chief Executive Officer
Eugene Andrew Bauer
Director & Chief Medical Officer